Discover CME, tools, and guideline-focused education to improve your knowledge - and patient outcomes.
Treat-to-Target: Are We There Yet?
Kimberly D. Orleck, PA-C
Jennifer Geremia, PA-C
Switching Strategies: Switch or Stay—What’s Your Call?
David Rubin, MD
Brooke Hodnick, PA-C, MPAS
Severity Assessment: Can You Pin the Stage on the Patient?
IBD Immunopathogenesis: Do You Know What You're Blocking?
From Flare to Farewell: The IBD Care Playbook for Advanced Practice Providers
When Topicals Fail: The New IPC Consensus Every Clinician Should Know
Linda Stein Gold, MD
Bruce Strober, MD, PhD
Beyond the Scalpel: When TGCT Surgery Isn’t the Solution
Michiel van de Sande, MD, PhD
The Safety Equation: Managing Adverse Events Associated With CSF1R Inhibitors in TGCT
A.J. Gelderblom, MD, PhD
Case Review: Can You Crack This IBD Case?
Case Review: Targets Are Met—Can You Stick the Landing?
Tailoring Treatment: Can You Select the Best Therapy?
The Tumor That’s Not So Tiny: Understanding the Impact of TGCT
Beyond the Joint: Cross-Specialty Solutions for Advancing TGCT Patient Care
Chelsea Cole, MD
Emerging Evidence in Focus: Interpreting Data on Next-Generation CSF1R TKIs
Diagnosing IBD: Is It IBD or Something Else? Can You Tell?
Unlocking the CSF1R Code: Targeted Pathways and Tailored Choices
Applying the Evidence: TGCT Treatment Insights for Sports Medicine Physicians
Clinical Evidence in Focus: Interpreting Data on Systemic Therapy Targeting CSF1R
All Sides of the Joint: Integrated TGCT Care Across Specialties
Taking Action Against RSV: No Child Unprotected
Tina Q. Tan, MD
Yvonne Maldonado, MD
Surgical Crossroads: Practical Considerations for Optimizing Treatment in TGCT
RSV in Infants and Young Children: Are You Taking It Seriously Enough?
A Clear Horizon in Plaque Psoriasis: An Update on Investigational Oral Therapies
April W. Armstrong, MD, MPH
MOA: CDH6-Targeted Antibody-Drug Conjugates
Kathleen Moore, MD, MS
Looking Ahead: Integrating CDH6-Targeted Therapies Into Ovarian Cancer Treatment Paradigms
Joyce F. Liu, MD, MPH
Safety and Tolerability of CDH6-Directed Antibody-Drug Conjugates
Loading...
We're glad to see you're enjoying Prova Education… but how about a more personalized experience?
Press cancel to remain on Prova Education. Press the link below or the continue button to keep going.